KALEIDO BIOSCIENCES INC (KLDO) Stock Income Statement
NASDAQ:KLDO - Nasdaq - US4833471000 - Common Stock
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.10M | 980.00K | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 88.77M | 79.85M | 86.66M | 60.68M | 27.03M | |||
| Research and Development | 67.80M | 55.97M | 64.23M | 42.06M | 20.99M | |||
| Selling, General, and Administrative Expenses | 20.97M | 23.88M | 22.43M | 18.62M | 6.04M | |||
| Operating Income | -87.67M | -78.87M | -86.66M | -60.68M | -27.03M | |||
| Interest Income/Expense | -2.77M | -2.55M | 970.00K | -810.00K | -510.00K | |||
| Other Income/Expense | 145.00K | -190.00K | -60.00K | -260.00K | -20.00K | |||
| Non Recurring Items | N/A | 0.00 | -580.00K | N/A | N/A | |||
| Income Before Taxes | -90.29M | -81.62M | -86.33M | -61.74M | -27.56M | |||
| Net Income | -90.29M | -81.62M | -86.33M | -61.74M | -27.56M | |||
| EBITDA | -85.31M | -77.05M | -85.34M | -59.89M | -26.71M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.16 | -2.44 | -3.36 | -2.10 | -0.94 | |||
| Non GAAP EPS | N/A | -2.44 | -3.74 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -8178.26% | -8328.57% | N/A | N/A | N/A | |||
| Operating Profit Margin | -7940.85% | -8047.96% | N/A | N/A | N/A | |||
All data in USD